253 related articles for article (PubMed ID: 30296683)
1. Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites.
L'abbate FP; Müller R; Openshaw R; Combrinck JM; de Villiers KA; Hunter R; Egan TJ
Eur J Med Chem; 2018 Nov; 159():243-254. PubMed ID: 30296683
[TBL] [Abstract][Full Text] [Related]
2. Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.
Wicht KJ; Combrinck JM; Smith PJ; Hunter R; Egan TJ
J Med Chem; 2016 Jul; 59(13):6512-30. PubMed ID: 27299916
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
4. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
de Villiers KA; Egan TJ
Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition.
Sharma K; Shrivastava A; Mehra RN; Deora GS; Alam MM; Zaman MS; Akhter M
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29227011
[TBL] [Abstract][Full Text] [Related]
6. Identification of β-hematin inhibitors in the MMV Malaria Box.
Fong KY; Sandlin RD; Wright DW
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ferrocenyl phosphines as potent antimalarials targeting the digestive vacuole function of Plasmodium falciparum.
Subramanian G; Sadeer A; Mukherjee K; Kojima T; Tripathi P; Naidu R; Tay SW; Pang JH; Pullarkat SA; Chandramohanadas R
Dalton Trans; 2019 Jan; 48(3):1108-1117. PubMed ID: 30605200
[TBL] [Abstract][Full Text] [Related]
8. Simplified Reversed Chloroquines To Overcome Malaria Resistance to Quinoline-Based Drugs.
Gunsaru B; Burgess SJ; Morrill W; Kelly JX; Shomloo S; Smilkstein MJ; Liebman K; Peyton DH
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193646
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles.
Rylands LI; Welsh A; Maepa K; Stringer T; Taylor D; Chibale K; Smith GS
Eur J Med Chem; 2019 Jan; 161():11-21. PubMed ID: 30342422
[TBL] [Abstract][Full Text] [Related]
10. Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
de Sousa ACC; Maepa K; Combrinck JM; Egan TJ
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235391
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of 2-aminobenzimidazoles as potent antimalarials.
Devine SM; Challis MP; Kigotho JK; Siddiqui G; De Paoli A; MacRaild CA; Avery VM; Creek DJ; Norton RS; Scammells PJ
Eur J Med Chem; 2021 Oct; 221():113518. PubMed ID: 34058708
[TBL] [Abstract][Full Text] [Related]
12. 4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice.
Joshi MC; Okombo J; Nsumiwa S; Ndove J; Taylor D; Wiesner L; Hunter R; Chibale K; Egan TJ
J Med Chem; 2017 Dec; 60(24):10245-10256. PubMed ID: 29185748
[TBL] [Abstract][Full Text] [Related]
13. Novel oxazine skeletons as potential antiplasmodial active ingredients: Synthesis, in vitro and in vivo biology of some oxazine entities produced via cyclization of novel chalcone intermediates.
Tiwari V; Meshram J; Ali P; Sheikh J; Tripathi U
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):569-78. PubMed ID: 21171899
[TBL] [Abstract][Full Text] [Related]
14. High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties.
Huy NT; Chi PL; Nagai J; Dang TN; Mbanefo EC; Ahmed AM; Long NP; Thoa LT; Hung LP; Titouna A; Kamei K; Ueda H; Hirayama K
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
Martiney JA; Cerami A; Slater AF
Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466
[TBL] [Abstract][Full Text] [Related]
16. Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action.
Kumar M; Okombo J; Mambwe D; Taylor D; Lawrence N; Reader J; van der Watt M; Fontinha D; Sanches-Vaz M; Bezuidenhout BC; Lauterbach SB; Liebenberg D; Birkholtz LM; Coetzer TL; Prudêncio M; Egan TJ; Wittlin S; Chibale K
ACS Infect Dis; 2019 Feb; 5(2):303-315. PubMed ID: 30525439
[TBL] [Abstract][Full Text] [Related]
17. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity.
Wicht KJ; Combrinck JM; Smith PJ; Egan TJ
Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.
Aguiar AC; Santos Rde M; Figueiredo FJ; Cortopassi WA; Pimentel AS; França TC; Meneghetti MR; Krettli AU
PLoS One; 2012; 7(5):e37259. PubMed ID: 22649514
[TBL] [Abstract][Full Text] [Related]
19. N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activity.
Figueiras M; Coelho L; Wicht KJ; Santos SA; Lavrado J; Gut J; Rosenthal PJ; Nogueira F; Egan TJ; Moreira R; Paulo A
Bioorg Med Chem; 2015 Apr; 23(7):1530-9. PubMed ID: 25725608
[TBL] [Abstract][Full Text] [Related]
20. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
